BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18796164)

  • 1. Somatic mutation analysis of MYH11 in breast and prostate cancer.
    Alhopuro P; Karhu A; Winqvist R; Waltering K; Visakorpi T; Aaltonen LA
    BMC Cancer; 2008 Sep; 8():263. PubMed ID: 18796164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unregulated smooth-muscle myosin in human intestinal neoplasia.
    Alhopuro P; Phichith D; Tuupanen S; Sammalkorpi H; Nybondas M; Saharinen J; Robinson JP; Yang Z; Chen LQ; Orntoft T; Mecklin JP; Järvinen H; Eng C; Moeslein G; Shibata D; Houlston RS; Lucassen A; Tomlinson IP; Launonen V; Ristimäki A; Arango D; Karhu A; Sweeney HL; Aaltonen LA
    Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5513-8. PubMed ID: 18391202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic Mutations and Intratumoral Heterogeneity of MYH11 Gene in Gastric and Colorectal Cancers.
    Jo YS; Kim MS; Yoo NJ; Lee SH
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):562-566. PubMed ID: 29517504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graded effects of unregulated smooth muscle myosin on intestinal architecture, intestinal motility and vascular function in zebrafish.
    Abrams J; Einhorn Z; Seiler C; Zong AB; Sweeney HL; Pack M
    Dis Model Mech; 2016 May; 9(5):529-40. PubMed ID: 26893369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
    Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 16p13.11 microdeletion uncovers loss-of-function of a MYH11 missense variant in a patient with megacystis-microcolon-intestinal-hypoperistalsis syndrome.
    Kloth K; Renner S; Burmester G; Steinemann D; Pabst B; Lorenz B; Simon R; Kolbe V; Hempel M; Rosenberger G
    Clin Genet; 2019 Jul; 96(1):85-90. PubMed ID: 31044419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic approaches to identify pathological limitations in aortic smooth muscle contraction.
    Huang J; Gao N; Wang S; Milewicz DM; Kamm KE; Stull JT
    PLoS One; 2018; 13(3):e0193769. PubMed ID: 29494672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-elongating mutations in MYH11 are implicated in a dominantly inherited smooth muscle dysmotility syndrome with severe esophageal, gastric, and intestinal disease.
    Gilbert MA; Schultz-Rogers L; Rajagopalan R; Grochowski CM; Wilkins BJ; Biswas S; Conlin LK; Fiorino KN; Dhamija R; Pack MA; Klee EW; Piccoli DA; Spinner NB
    Hum Mutat; 2020 May; 41(5):973-982. PubMed ID: 31944481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smooth-muscle myosin mutations in hereditary non-polyposis colorectal cancer syndrome.
    Vickaryous N; Polanco-Echeverry G; Morrow S; Suraweera N; Thomas H; Tomlinson I; Silver A
    Br J Cancer; 2008 Nov; 99(10):1726-8. PubMed ID: 18941465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Characterization of KRAS, BRAF, and EGFR Genes in Cases with Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations.
    Salmaninejad A; Ghadami S; Dizaji MZ; Golchehre Z; Estiar MA; Zamani MR; Ebrahimzadeh-Vesal R; Nowroozi MR; Shakoori A
    Clin Lab; 2015; 61(7):749-59. PubMed ID: 26299074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice.
    Saida S; Zhen T; Kim E; Yu K; Lopez G; McReynolds LJ; Liu PP
    Leukemia; 2020 Mar; 34(3):759-770. PubMed ID: 31624376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A homozygous loss-of-function variant in MYH11 in a case with megacystis-microcolon-intestinal hypoperistalsis syndrome.
    Gauthier J; Ouled Amar Bencheikh B; Hamdan FF; Harrison SM; Baker LA; Couture F; Thiffault I; Ouazzani R; Samuels ME; Mitchell GA; Rouleau GA; Michaud JL; Soucy JF
    Eur J Hum Genet; 2015 Sep; 23(9):1266-8. PubMed ID: 25407000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of the DNA glycosylase gene MUTYH is associated with an increased number of somatic mutations via a reduction in the DNA repair capacity in prostate adenocarcinoma.
    Shinmura K; Kato H; Kawanishi Y; Yoshimura K; Igarashi H; Goto M; Tao H; Inoue Y; Sugiyama T; Furuse H; Ozono S; Sugimura H
    Mol Carcinog; 2017 Feb; 56(2):781-788. PubMed ID: 27253753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Variant in the MYH11 Gene in a Familial Case of Thoracic Aortic Aneurysm.
    Pucci L; Pointet A; Good JM; Davoine E; Cina V; Zanchi F; Deglise S; Duchosal LM; Kirsch M
    Ann Thorac Surg; 2020 Apr; 109(4):e279-e281. PubMed ID: 31473177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers.
    Kim MS; Je EM; Oh JE; Yoo NJ; Lee SH
    APMIS; 2013 Jul; 121(7):626-33. PubMed ID: 23216165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II.
    Pannu H; Tran-Fadulu V; Papke CL; Scherer S; Liu Y; Presley C; Guo D; Estrera AL; Safi HJ; Brasier AR; Vick GW; Marian AJ; Raman CS; Buja LM; Milewicz DM
    Hum Mol Genet; 2007 Oct; 16(20):2453-62. PubMed ID: 17666408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
    Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
    Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer.
    Schlechte H; Lenk SV; Löning T; Schnorr D; Rudolph BD; Ditscherlein G; Loening SA
    Eur Urol; 1998; 34(5):433-40. PubMed ID: 9803007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice.
    Hyde RK; Zhao L; Alemu L; Liu PP
    Leukemia; 2015 Aug; 29(8):1771-8. PubMed ID: 25742748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of smooth muscle myosin causes epithelial invasion and cystic expansion of the zebrafish intestine.
    Wallace KN; Dolan AC; Seiler C; Smith EM; Yusuff S; Chaille-Arnold L; Judson B; Sierk R; Yengo C; Sweeney HL; Pack M
    Dev Cell; 2005 May; 8(5):717-26. PubMed ID: 15866162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.